Apixaban Impurity 163 | CAS 1819984-23-0 - Request Quote
Apixaban Impurity 163
| SZ CAT No: | SZ-A062215 |
| CAS No | 1819984-23-0 |
| Mol.F. | C16H20N4O3 |
| Mol.Wt. | 316.4 |
| Inv. Status | Synthesis on demand |
Chemical Name :
Shipping Temperature :
HSN Code :
Country of Origin :
Smiles :
Usage Note:
Apixaban Impurity 163 is chemically 3-(4-Methylpiperazin-1-yl)-1-(4-nitrophenyl)-5,6-dihydropyridin-2(1H)-one. Apixaban Impurity 163 is supplied with detailed characterization data compliant with regulatory guideline. Apixaban Impurity 163 can be used for the analytical method development, method validation (AMV), Quality Controlled (QC) application for Abbreviated New Drug Application (ANDA) or during commercial production of Apixaban.
The product can be used as reference standards and further traceability against pharmacopeial standards (USP or EP) can be provided based on feasibility. SynZeal products are for analytical purpose only and not for human use.
Applications & Regulatory Use Cases
Buy 1819984-23-0
Purchase 1819984-23-0
Order 1819984-23-0
Enquire 1819984-23-0
price of 1819984-23-0
1819984-23-0 Supplier
1819984-23-0 Manufacturer
1819984-23-0 Exporter
buy high quality Apixaban Impurity 163
Purchase Apixaban Impurity 163
Apixaban Impurity 163 suppliers
Apixaban Impurity 163 manufacturers
Apixaban Impurity 163 price
Order Apixaban Impurity 163
Enquire Apixaban Impurity 163
Apixaban Impurity 163 cost
Apixaban Impurity 163 Supplier
Apixaban Impurity 163 Distributor
Apixaban Impurity 163 for Method Validation
Apixaban Reference Standard
Apixaban Impurity 163 for ANDA Filing
Apixaban Impurity 163 for Forced Degradation Studies
Apixaban Impurity 163 Identification Standards
Apixaban Impurity 163 for DMF Filing
Related Products
Disclaimer
SynZeal product information given on this website is as per the existing understanding while publishing the details on website. The customer is responsible for assessing the accuracy of the information at the time of actual purchase.
SynZeal will update these details as per new developments or findings in product specifications without further notice.